Cutler Group LP Bio Line Rx Ltd. Transaction History
Cutler Group LP
- $307 Million
- Q1 2024
A detailed history of Cutler Group LP transactions in Bio Line Rx Ltd. stock. As of the latest transaction made, Cutler Group LP holds 2,000 shares of BLRX stock, worth $7,720. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,000Holding current value
$7,720% of portfolio
0.0%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding BLRX
# of Institutions
37Shares Held
2.99MCall Options Held
75.1KPut Options Held
5.1K-
Highbridge Capital Management LLC New York, NY1.01MShares$3.9 Million0.05% of portfolio
-
Cvi Holdings, LLC Wilmington, DE816KShares$3.15 Million4.05% of portfolio
-
Values First Advisors, Inc.166KShares$642,4930.02% of portfolio
-
Pvg Asset Management Corp Golden, CO157KShares$606,8490.37% of portfolio
-
Atria Wealth Solutions, Inc. New York, NY94.1KShares$363,3530.0% of portfolio
About BioLineRx Ltd.
- Ticker BLRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 61,524,500
- Market Cap $237M
- Description
- BioLineRx Ltd., a clinical-stage biopharmaceutical development company, focuses on oncology. The company develops Motixafortide, a peptide, which has completed Phase 3 clinical trials for the treatment of autologous stem cell mobilization and Phase 2a clinical trials for the treatment of pancreatic cancer; and that is in Phase 2 clinical trials ...